Skip to main content

Table 3 EGFR mutation status of adenocarcinoma patients

From: Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review

 

N = 91 (%)

Not available

68 (75)

Tested

23 (25)

EGFR negative

15 (65)

Insufficient material

6 (26)

EGFR positive

2 (9)

  1. EGFR: Epidermal growth factor receptor.